Amyotrophic Lateral Sclerosis Treatment Market Expected To Expand At A CAGR of 5.8% From 2019 To 2026

San Francisco, 24 Nov 2020: The Report Amyotrophic Lateral Sclerosis Treatment Market Size, Share & Trends Analysis Report By Treatment (Medication, Stem Cell Transplant), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), And Segment Forecasts, 2019 - 2026

The global amyotrophic lateral sclerosis treatment market size is expected to reach USD 885.5 million by 2026, according to a new report by Grand View Research. Some of the key factors driving the market include growing awareness about ALS, increasing incidence rate, and rising geriatric population. However, the cost associated with ALS treatment is high, which may hinder the market growth during the forecast period.

Currently, no cure is available for ALS and treatments such as medications and stem cell therapies can only help to slow down the disease progression, manage the symptoms, and prevent unnecessary complications. Furthermore, inclination towards a sedentary lifestyle among the geriatric population increases the risk of developing the disorder that increases the demand for new targeted treatment options and therapeutic approaches. According to the U.S. Department of Health Resources & Services, the estimated prevalence of amyotrophic lateral sclerosis in the U.S. was 5.2 per 100,000 people and 16,583 cases of ALS were reported in 2015.

Among the treatments, the medications acquired the largest market share in 2018 and is expected to dominate the ALS market over the forecast period. Currently, only two drugs have been approved for use in ALS treatment, Rilutek (riluzole) and Radicava (edaravone). Nuedexta (dextromethorphan/quinidine) in another drug used in ALS treatments, however, it has been approved to treat the pseudobulbar affect (PBA), a comorbidity of ALS.  North America held the leading position in the amyotrophic lateral sclerosis market in 2018, while Asia Pacific is projected to grow the fastest among all regions through the forecast period.

Access Research Report of Amyotrophic Lateral Sclerosis Treatment Market https://www.grandviewresearch.com/industry-analysis/amyotrophic-lateral-sclerosis-treatment-market

Amyotrophic Lateral Sclerosis Treatment Market Report Highlights

  • Medications held the largest market share in the treatment segment. Although, there is no cure for ALS, the approved medications such as riluzole and edaravone help in managing symptoms and delaying the disease progression.
  • Stem cell therapy is expected to demonstrate the highest CAGR among the treatment over the forecast period due to the increasing demand for new approaches and advanced treatment options
  • Asia Pacific regional market is projected to demonstrate the fastest growth during the forecast period due to rising disposable income and improving healthcare infrastructure
  • Some of the major companies operating in this market include Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F. Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, and Ionis Pharmaceuticals, Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the ALS treatment market report on the basis of treatment, distribution channel, and region:

Treatment Outlook (Revenue, USD Million, 2015 - 2026)

  • Medication
  • Stem Cell Therapy
  • Others

Distribution Channel Outlook (Revenue, USD Million, 2015 - 2026)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East & Africa

Access Press Release of Amyotrophic Lateral Sclerosis Treatment Market @ https://www.grandviewresearch.com/press-release/global-amyotrophic-lateral-sclerosis-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

 

Comments

Popular posts from this blog

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028

Gas Detection Equipment Market Anticipated To Expand At A CAGR 9.7% From 2021 To 2028